Chemcon Pharma Chem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 26-06-2024
- Paid Up Capital ₹ 0.15 M
as on 26-06-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Ebitda
- Net Worth
- Total Assets 0.52%
(FY 2022)
About Chemcon Pharma Chem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Surender Goyal and Vijender Goel serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC053060
- Company No.
053060
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Feb 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Chemcon Pharma Chem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surender Goyal  | Director | 03-Feb-2014 | Current |
| Vijender Goel | Director | 03-Feb-2014 | Current |
Financial Performance of Chemcon Pharma Chem.
Chemcon Pharma Chem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Chemcon Pharma Chem?
In 2020, Chemcon Pharma Chem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
_PRIVATE_LIMITED.webp)
Panoli Intermediates (India) Private LimitedActive 26 years 2 monthsSurender Goyal and Vijender Goel are mutual person
Kutch Chemical Industries LimitedActive 22 years 6 monthsSurender Goyal and Vijender Goel are mutual person
Gandhar Petrochemicals LimitedActive 13 years 5 monthsSurender Goyal and Vijender Goel are mutual person
- Durgesh Chemicals Private LimitedActive 33 years 5 months
Surender Goyal and Vijender Goel are mutual person
- Kutch Specialities Private LimitedActive 5 years 21 days
Surender Goyal and Vijender Goel are mutual person
- Karna Properties Private LimitedActive 35 years 7 months
Surender Goyal and Vijender Goel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemcon Pharma Chem?
Unlock and access historical data on people associated with Chemcon Pharma Chem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemcon Pharma Chem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemcon Pharma Chem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
